201 related articles for article (PubMed ID: 33668161)
1. Chitosan Nanocarrier Entrapping Hydrophilic Drugs as Advanced Polymeric System for Dual Pharmaceutical and Cosmeceutical Application: A Comprehensive Analysis Using Box-Behnken Design.
Abosabaa SA; ElMeshad AN; Arafa MG
Polymers (Basel); 2021 Feb; 13(5):. PubMed ID: 33668161
[TBL] [Abstract][Full Text] [Related]
2. Hybrid chitosan-lipid nanoparticles of green tea extract as natural anti-cellulite agent with superior
Abosabaa SA; Arafa MG; ElMeshad AN
Drug Deliv; 2021 Dec; 28(1):2160-2176. PubMed ID: 34623203
[TBL] [Abstract][Full Text] [Related]
3. Development of a Curcumin-Loaded Lecithin/Chitosan Nanoparticle Utilizing a Box-Behnken Design of Experiment: Formulation Design and Influence of Process Parameters.
Walbi IA; Ahmad MZ; Ahmad J; Algahtani MS; Alali AS; Alsudir SA; Aodah AH; Albarqi HA
Polymers (Basel); 2022 Sep; 14(18):. PubMed ID: 36145903
[TBL] [Abstract][Full Text] [Related]
4. Formulation of simvastatin chitosan nanoparticles for controlled delivery in bone regeneration: Optimization using Box-Behnken design, stability and in vivo study.
Delan WK; Zakaria M; Elsaadany B; ElMeshad AN; Mamdouh W; Fares AR
Int J Pharm; 2020 Mar; 577():119038. PubMed ID: 31953085
[TBL] [Abstract][Full Text] [Related]
5. Formulation optimization of scutellarin-loaded HP-β-CD/chitosan nanoparticles using response surface methodology with Box-Behnken design.
Liu S; Ho PC
Asian J Pharm Sci; 2017 Jul; 12(4):378-385. PubMed ID: 32104349
[TBL] [Abstract][Full Text] [Related]
6. Development and Optimization of Ciprofloxacin HCl-Loaded Chitosan Nanoparticles Using Box-Behnken Experimental Design.
Soliman NM; Shakeel F; Haq N; Alanazi FK; Alshehri S; Bayomi M; Alenazi ASM; Alsarra IA
Molecules; 2022 Jul; 27(14):. PubMed ID: 35889340
[TBL] [Abstract][Full Text] [Related]
7. Development, optimization, and in vitro characterization of dasatinib-loaded PEG functionalized chitosan capped gold nanoparticles using Box-Behnken experimental design.
Adena SKR; Upadhyay M; Vardhan H; Mishra B
Drug Dev Ind Pharm; 2018 Mar; 44(3):493-501. PubMed ID: 29161920
[TBL] [Abstract][Full Text] [Related]
8. Application of Box-Behnken experimental design for the formulation and optimisation of selenomethionine-loaded chitosan nanoparticles coated with zein for oral delivery.
Vozza G; Danish M; Byrne HJ; Frías JM; Ryan SM
Int J Pharm; 2018 Nov; 551(1-2):257-269. PubMed ID: 30153488
[TBL] [Abstract][Full Text] [Related]
9. "Application of Box-Behnken design for optimization and development of quetiapine fumarate loaded chitosan nanoparticles for brain delivery via intranasal route* ".
Shah B; Khunt D; Misra M; Padh H
Int J Biol Macromol; 2016 Aug; 89():206-18. PubMed ID: 27130654
[TBL] [Abstract][Full Text] [Related]
10. Chitosan Nanoparticles for Enhanced Delivery of
Alam P; Imran M; Ahmed S; Majid H; Akhtar A
Pharmaceuticals (Basel); 2023 Nov; 16(11):. PubMed ID: 38004427
[TBL] [Abstract][Full Text] [Related]
11. Formulation, optimization and characterization of cationic polymeric nanoparticles of mast cell stabilizing agent using the Box-Behnken experimental design.
Gajra B; Patel RR; Dalwadi C
Drug Dev Ind Pharm; 2016; 42(5):747-57. PubMed ID: 26559522
[TBL] [Abstract][Full Text] [Related]
12. Statistical modeling of zaltoprofen loaded biopolymeric nanoparticles: Characterization and anti-inflammatory activity of nanoparticles loaded gel.
Shah HA; Patel RP
Int J Pharm Investig; 2015; 5(1):20-7. PubMed ID: 25599029
[TBL] [Abstract][Full Text] [Related]
13. Development of Timolol Maleate Loaded Chitosan Nanoparticles For Improved Ocular Delivery.
Saroha A; Pandey P; Kaushik D
Pharm Nanotechnol; 2017; 5(4):310-316. PubMed ID: 28847270
[TBL] [Abstract][Full Text] [Related]
14. Preparation, optimization, and characterization of chitosan-coated solid lipid nanoparticles for ocular drug delivery.
Wang FZ; Zhang MW; Zhang DS; Huang Y; Chen L; Jiang SM; Shi K; Li R
J Biomed Res; 2018 Nov; 32(5):411-423. PubMed ID: 30174319
[TBL] [Abstract][Full Text] [Related]
15. Chitosan-TPP nanoparticles stabilized by poloxamer for controlling the release and enhancing the bioavailability of doxazosin mesylate:
Aljaeid BM; El-Say KM; Hosny KM
Drug Dev Ind Pharm; 2019 Jul; 45(7):1130-1139. PubMed ID: 30884977
[No Abstract] [Full Text] [Related]
16. Development and Characterization of Gefitinib Loaded Polymeric Nanoparticles by Ionic Gelation Method.
Gupta M; Marwaha RK; Dureja H
Pharm Nanotechnol; 2017; 5(4):301-309. PubMed ID: 28982345
[TBL] [Abstract][Full Text] [Related]
17. Design and Development of Lomustine Loaded Chitosan Nanoparticles for Efficient Brain Targeting.
Anand A; Iyer BR; Ponnusamy C; Pandiyan R; Sugumaran A
Cardiovasc Hematol Agents Med Chem; 2020; 18(1):45-54. PubMed ID: 32013840
[TBL] [Abstract][Full Text] [Related]
18. Hyaluronic Acid-Coated Chitosan/Gelatin Nanoparticles as a New Strategy for Topical Delivery of Metformin in Melanoma.
Ebrahimnejad P; Rezaeiroshan A; Babaei A; Khanali A; Aghajanshakeri S; Farmoudeh A; Nokhodchi A
Biomed Res Int; 2023; 2023():3304105. PubMed ID: 37313551
[TBL] [Abstract][Full Text] [Related]
19. Fabrication, Optimization, and Evaluation of Rotigotine-Loaded Chitosan Nanoparticles for Nose-To-Brain Delivery.
Tzeyung AS; Md S; Bhattamisra SK; Madheswaran T; Alhakamy NA; Aldawsari HM; Radhakrishnan AK
Pharmaceutics; 2019 Jan; 11(1):. PubMed ID: 30634665
[TBL] [Abstract][Full Text] [Related]
20. Formulation of Chitosan Polymeric Vesicles of Ciprofloxacin for Ocular Delivery: Box-Behnken Optimization, In Vitro Characterization, HET-CAM Irritation, and Antimicrobial Assessment.
Ameeduzzafar ; Alruwaili NK; Imam SS; Alotaibi NH; Alhakamy NA; Alharbi KS; Alshehri S; Afzal M; Alenezi SK; Bukhari SNA
AAPS PharmSciTech; 2020 Jun; 21(5):167. PubMed ID: 32504176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
